Queen Mary scientists find faulty gene causing rare oesophageal cancer
New medical research in London’s East End has uncovered a gene which plays a key role in developing cancer of the gullet.
Researchers from Queen Mary, University of London, found that a fault in the gene known as RHBDF2 was responsible for oesophageal cancer in anyone carrying a rare, inherited condition called Tylosis—the faulty gene made them highly susceptible to the disease.
“Finding a genetic cause for this aggressive cancer and understanding what that gene is doing is an enormous step forward,” said Prof David Kelsell who led the study at Queen Mary’s.
“Analysing the complex biology which causes a particular cancer means we begin to understand which treatments might be effective and which are unlikely to help.”
Oesophageal cancer affects 8,000 people a year in Britain and is more common than anywhere else in Europe. Survival rates are poor, with only eight per cent living five years after diagnosis.
You may also want to watch:
Scientists have known little about how it develops or what drugs currently available could target the disease, until now.
- 1 'Stop building more towers,' MP at protest after New Providence Wharf fire
- 2 Racist vandalism keyed on cars parked in street on Isle of Dogs
- 3 Leyton Orient have announced their retained list as they begin rebuild
- 4 Tower Hamlets votes to keep directly-elected mayoral post
- 5 'Halt to development draining services' after win for neighbourhood plan
- 6 Groomed girl speaks out after 'dangerous' Barking dealer who dealt Class A drugs in East End is jailed
- 7 MP's fury at four-year delay removing Grenfell-type cladding from block
- 8 Masks scrapped 'as early as next month' and over 35s jabs 'soon'
- 9 Blaze at Canary Wharf tower block with cladding issue
- 10 Unmesh Desai on his priorities after winning City and East election